RTA compliance certificate for Q2 FY27 dematerialisation filed

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.8%Reaction day

₹67.70

prior close

₹68.31

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+0.5% vs market

Healthcare Services peers, median of 66sector · industry level-0.3%+2.1% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 2.1 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.6

10m

+3.8

15m

+1.1

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.8+1.3+0.5-0.3+2.1

Next day

+0.4+1.1-0.6-0.5+1.0

-1.0-1.7+0.7-2.4+1.3

+1.2-1.5+2.6-0.8+2.0

-4.7-0.6-4.1-1.2-3.5

-5.5-0.4-5.0-2.7-2.8

-6.9-1.4-5.6-1.6-5.4

15d

-9.7pendingpending-4.9-4.8

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 66Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Novelix Pharmaceuticals (formerly Trimurthi Limited) submitted a certificate from its Registrar and Share Transfer Agent, Venture Capital and Corporate Investments, under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The RTA confirmed that physical shares received for dematerialisation were mutilated, cancelled, and updated in NSD and CDS records within 15 days. This is a routine quarterly filing required by SEBI depositories regulations.

Likely market impact

Routine regulatory compliance filing. No material impact on business or shareholders.